United Therapeutics Corp. (UTHR)
515.31
-12.60
(-2.39%)
USD |
NASDAQ |
Aug 28, 16:00
515.31
0.00 (0.00%)
After-Hours: 17:53
United Therapeutics Cash from Operations (Quarterly) : 310.20M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 310.20M |
| March 31, 2026 | 463.30M |
| December 31, 2025 | 346.20M |
| September 30, 2025 | 562.10M |
| June 30, 2025 | 191.70M |
| March 31, 2025 | 461.20M |
| December 31, 2024 | 341.20M |
| September 30, 2024 | 374.50M |
| June 30, 2024 | 232.20M |
| March 31, 2024 | 376.50M |
| December 31, 2023 | 153.40M |
| September 30, 2023 | 346.20M |
| June 30, 2023 | 106.30M |
| March 31, 2023 | 372.10M |
| December 31, 2022 | 120.70M |
| September 30, 2022 | 258.60M |
| June 30, 2022 | 127.00M |
| March 31, 2022 | 288.70M |
| December 31, 2021 | 174.60M |
| September 30, 2021 | 185.60M |
| June 30, 2021 | 148.20M |
| March 31, 2021 | 89.80M |
| December 31, 2020 | 124.50M |
| September 30, 2020 | 250.90M |
| June 30, 2020 | 164.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 214.60M |
| December 31, 2019 | 102.50M |
| September 30, 2019 | 185.40M |
| June 30, 2019 | 132.90M |
| March 31, 2019 | -627.40M |
| December 31, 2018 | 118.40M |
| September 30, 2018 | 204.50M |
| June 30, 2018 | 179.80M |
| March 31, 2018 | 275.70M |
| December 31, 2017 | -85.80M |
| September 30, 2017 | 258.50M |
| June 30, 2017 | 70.70M |
| March 31, 2017 | 230.80M |
| December 31, 2016 | 163.40M |
| September 30, 2016 | 228.70M |
| June 30, 2016 | 125.70M |
| March 31, 2016 | 125.80M |
| December 31, 2015 | 25.52M |
| September 30, 2015 | 207.31M |
| June 30, 2015 | 40.98M |
| March 31, 2015 | 108.95M |
| December 31, 2014 | 90.60M |
| September 30, 2014 | 208.54M |
| June 30, 2014 | -54.48M |
| March 31, 2014 | 110.60M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Liquidia Corp. | 80.24M |
| Insmed, Inc. | -88.83M |
| MannKind Corp. | -18.63M |
| Vertex Pharmaceuticals, Inc. | 1.125B |
| BioMarin Pharmaceutical, Inc. | 168.11M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 87.50M |
| Cash from Financing (Quarterly) | 125.80M |
| Free Cash Flow | 1.084B |
| Free Cash Flow Per Share (Quarterly) | 4.415 |
| Free Cash Flow to Equity (Quarterly) | 202.20M |
| Free Cash Flow to Firm (Quarterly) | 204.79M |
| Free Cash Flow Yield | 4.49% |